NovaBridge Biosciences Income Statement (2017-2025) | NBP

Income Statement Dec2017 Dec2018 Sep2019 Dec2019 Sep2020 Dec2020 Dec2021 Dec2022 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Revenue & cost
Revenue (Quarter) 0.00B0.00B0.00B0.00B
Cost of Revenue (Quarter) -40.89B
Gross Profit (Quarter) 40.89B
Operating items
Research & Development (Quarter) -0.04B0.20B-0.10B0.33B0.03B-0.00B-0.01B0.03B-0.01B-0.01B-0.00B0.01B-0.00B-0.00B0.01B0.06B
Share-based Compensation (IS) (Quarter) 0.00B0.00B0.00B0.00B
Selling, General & Administrative (Quarter) -0.00B0.18B-0.04B-0.01B-0.01B-0.01B0.05B-0.00B-0.01B-0.01B0.05B-0.00B-0.00B-0.01B0.05B
Other Operating Expenses (Quarter) -0.07B-0.01B-0.17B
Operating Expenses (Quarter) -0.05B0.38B-0.15B0.32B-0.01B0.08B-0.01B-0.02B-0.01B-0.01B-0.01B-0.01B-0.01B-0.07B
Operating Income (Quarter) -0.04B-0.05B88.52B-0.01B-0.01B-0.01B-0.04B-0.01B-0.02B-0.01B-0.01B-0.01B-0.01B-0.01B-0.07B
EBIT (Quarter) -0.04B-0.05B88.52B-0.01B-0.01B-0.01B-0.04B-0.01B-0.02B-0.01B-0.01B-0.01B-0.01B-0.01B-0.07B
Non-operating items
Interest & Investment Income (Quarter) 0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B
Other Non Operating Income (Quarter) 0.00B-0.00B0.06B-0.00B-0.02B0.00B0.00B-0.00B0.01B-0.01B0.00B0.00B-0.00B0.00B-0.00B
Net income details
EBT (Quarter) -0.04B-0.05B-0.08B0.16B-0.03B-0.01B-0.04B-0.01B-0.01B-0.02B-0.01B-0.00B-0.01B-0.01B-0.07B
Tax Provisions (Quarter) -0.00B
Profit After Tax (Quarter) -0.04B-0.36B-0.08B-0.01B-0.03B0.01B-0.04B-0.02B0.03B-0.02B0.01B-0.00B-0.01B0.02B-0.10B
Equity Income (Quarter) 0.01B-0.00B-0.00B-0.00B-0.00B0.00B
Income from Continuing Operations (Quarter) -0.04B-0.05B-0.08B0.16B-0.03B-0.01B-0.04B-0.01B-0.01B-0.02B-0.01B-0.00B-0.01B-0.01B-0.07B
Consolidated Net Income (Quarter) -0.04B-0.05B-0.08B0.16B0.03B0.03B-0.01B0.03B0.03B-0.00B-0.01B-0.01B-0.07B
Income towards Parent Company (Quarter) -0.04B-0.05B-0.08B0.16B0.03B-0.03B-0.01B0.03B0.03B-0.00B-0.01B-0.01B-0.07B
Net Income towards Common Stockholders (Quarter) -0.04B-0.05B-0.08B0.16B0.03B-0.01B0.03B0.02B-0.00B-0.01B-0.01B-0.07B
Additional items
EPS (Basic) (Quarter) -51.70-5.387.760.180.17-2.51-0.00B0.00B0.00B-0.00B-0.00B-0.00B-0.33
EPS (Weighted Average and Diluted) (Quarter) -51.700.00B-2.510.00B0.00B-0.00B-0.00B-0.33
Shares Outstanding (Weighted Average) (Quarter) 0.00B0.00B0.00B0.02B0.02B0.03B0.03B0.19B0.19B0.03B50.00100.00210.00120.0020.0050.0080.000.22B
Shares Outstanding (Diluted Average) (Quarter) 0.00B0.00B0.00B452.680.03B0.03B0.03B110.00140.00110.00170.000.22B
EBITDA (Quarter) -0.04B-0.05B88.52B-0.01B-0.01B-0.01B-0.04B0.02B0.03B-0.00B-0.04B-0.00B0.00B0.01B-0.07B
Interest Expenses (Quarter) -0.00B0.00B-0.00B
Tax Rate (Quarter) -1.16%